Ranibizumab and its use in the treatment of diabetic macular edema
| dc.contributor.advisor | Pórszász, Róbert | |
| dc.contributor.advisordept | Debreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézet | hu_HU |
| dc.contributor.author | Tieger, Leonardo | |
| dc.contributor.department | DE--Általános Orvostudományi Kar | hu_HU |
| dc.contributor.opponent | Szentmiklósi, József András | |
| dc.contributor.opponent | Drimba, László | |
| dc.contributor.opponentdept | Debreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézet | hu_HU |
| dc.contributor.opponentdept | Kenézy Kórház Központi Aneszteziológiai és Intenzív Terápiás Osztály | hu_HU |
| dc.date.accessioned | 2018-11-19T12:35:57Z | |
| dc.date.available | 2018-11-19T12:35:57Z | |
| dc.date.created | 2018-03 | |
| dc.description.abstract | The dissertation concerns the use of the vascular endothelian growth factor inhibitor medication known as Ranibizumab in the treatment of patients affected by diabetic macular edema, while comparing its effectiveness with other contemporary forms of treatments such as steroids, laser photocoagulation and similar VEGF inhibitors. | hu_HU |
| dc.description.corrector | SZG | |
| dc.description.corrector | hbk | |
| dc.description.course | általános orvos | hu_HU |
| dc.description.courselang | angol | hu_HU |
| dc.description.degree | egységes, osztatlan | hu_HU |
| dc.format.extent | 55 | hu_HU |
| dc.identifier.uri | http://hdl.handle.net/2437/259306 | |
| dc.language.iso | en | hu_HU |
| dc.subject | Ranibizumab | hu_HU |
| dc.subject | VEGF | hu_HU |
| dc.subject | Diabetic macular edema | hu_HU |
| dc.subject | Macular Edema | hu_HU |
| dc.subject | Diabetes | hu_HU |
| dc.subject.dspace | DEENK Témalista::Orvostudomány | hu_HU |
| dc.title | Ranibizumab and its use in the treatment of diabetic macular edema | hu_HU |